Thiazolidinediones are a family of insulin-sensitizing drugs that have been identified to have potential therapeutic benefits in treating AD due to their unique agonists of the gamma receptor for peroxisome proliferator (PPAR). Here, PPARA is linked to Alzheimer disease.